Savara Ownership | Who Owns Savara?

Overview Forecast RevenueFinancials Chart

Savara Ownership Summary

Savara is owned by 34.26% institutional investors, 5.35% insiders, and 60.39% retail investors. Nea management company is the largest institutional shareholder, holding 11.55% of SVRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.96% of its assets in Savara shares.

SVRA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Savara	34.26%	5.35%	60.39%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nea management company	24.47M	11.55%	$75.13M
Bain capital life sciences investors	17.60M	8.88%	$48.75M
Tcg crossover management	12.36M	5.84%	$37.95M
Frazier life sciences management	11.46M	5.78%	$31.75M
Vestal point capital, lp	11.00M	5.55%	$30.47M
Blackrock funding, inc. /de	9.59M	4.53%	$29.44M
Blackrock	8.03M	4.40%	$32.36M
Nantahala capital management	8.08M	4.07%	$22.37M
Deerfield management company, l.p. (series c)	7.96M	4.02%	$22.06M
Vanguard group	8.31M	3.92%	$25.51M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bain capital life sciences investors	17.60M	7.21%	$48.75M
Nea management company	24.47M	4.24%	$75.13M
Rosalind advisors	2.65M	4.17%	$8.15M
Tcg crossover management	12.36M	3.71%	$37.95M
Vestal point capital, lp	11.00M	2.18%	$30.47M
Exome asset management	836.40K	2.06%	$2.32M
Frazier life sciences management	11.46M	1.45%	$31.75M
Superstring capital management lp	508.34K	1.35%	$1.56M
Ghost tree capital	1.05M	1.33%	$4.24M
Sofinnova investments	5.48M	0.99%	$15.18M

Top Buyers

Holder	Shares	% Assets	Change
Vr adviser	3.26M	0.77%	3.26M
Bain capital life sciences investors	17.60M	7.21%	3.04M
Frazier life sciences management	11.46M	1.45%	2.80M
Rosalind advisors	2.65M	4.17%	2.65M
Emerald advisers	2.33M	0.28%	2.33M

Top Sellers

Holder	Shares	% Assets	Change
Jennison associates	-	-	-6.73M
Wellington management group llp	5.48M	0.00%	-3.14M
Exoduspoint capital management, lp	-	-	-2.79M
Adage capital partners gp	-	-	-2.12M
Vivo capital	-	-	-2.09M

New Positions

Holder	Shares	% Assets	Change	Value
Vr adviser	3.26M	0.77%	3.26M	$9.02M
Rosalind advisors	2.65M	4.17%	2.65M	$8.15M
Emerald advisers	2.33M	0.28%	2.33M	$7.16M
Emerald mutual fund advisers trust	1.38M	0.26%	1.38M	$4.22M
Point72 asset management	700.99K	0.00%	700.99K	$2.15M

Sold Out

Holder	Change
Federated hermes	-3.00
Nelson, van denburg & campbell wealth management group	-16.00
Signaturefd	-30.00
Gamma investing	-60.00
Pnc financial services group	-62.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	12	-91.18%	67,904,042	-58.30%	34	0.58%	10	-87.50%	1	-96.88%
Dec 31, 2024	39	-69.53%	26,754,956	-83.33%	12	0.22%	21	-71.62%	8	-69.23%
Sep 30, 2024	128	-11.72%	160,502,555	8.32%	75	1.15%	74	-15.91%	26	-10.34%
Jun 30, 2024	145	16.94%	148,180,451	22.39%	81	1.85%	88	8.64%	29	26.09%
Mar 31, 2024	124	25.25%	121,071,741	1.76%	66	1.28%	81	39.66%	23	21.05%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.12M	2.96%	-
Vanguard US Total Market Shares ETF	4.93M	2.86%	-
Jennison Health Sciences Equity	3.78M	2.29%	463.66K
PGIM Jennison Health Sciences Z	3.78M	2.21%	-
iShares Russell 2000 ETF	3.09M	1.79%	1.51K
Vanguard Institutional Extnd Mkt Idx Tr	1.66M	0.96%	20.51K
SPDR® S&P Biotech ETF	1.56M	0.91%	-9.50K
Fidelity Small Cap Index	1.15M	0.67%	-
Emerald Growth A	1.08M	0.63%	-
UTM IM GBP AXA Framlington Biotech	1.01M	0.58%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 29, 2025	McCracken Joseph S	-	Buy	$20.82K
Mar 31, 2025	RAMSAY DAVID A	-	Buy	$416.25K
Dec 16, 2024	Lowrance David L	Chief Financial Officer	Sell	$83.28K
Dec 16, 2024	Pauls Matthew	CHIEF EXECUTIVE OFFICER	Sell	$180.83K
Dec 16, 2024	Hawkins Richard J	-	Sell	$26.57K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	1	-
2024 Q4	2	3
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

SVRA Ownership FAQ

Who Owns Savara?

Savara shareholders are primarily institutional investors at 34.26%, followed by 5.35% insiders and 60.39% retail investors. The average institutional ownership in Savara's industry, Biotech Stocks , is 63.97%, which Savara falls below.

Who owns the most shares of Savara?

Savara’s largest shareholders are Nea management company (24.47M shares, 11.55%), Bain capital life sciences investors (17.6M shares, 8.88%), and Tcg crossover management (12.36M shares, 5.84%). Together, they hold 26.27% of Savara’s total shares outstanding.

Does Blackrock own Savara?

Yes, BlackRock owns 4.40% of Savara, totaling 8.03M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.36M$. In the last quarter, BlackRock increased its holdings by 788.8K shares, a 10.89% change.

Who is Savara’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Savara’s biggest shareholder by percentage of total assets invested, with 7.21% of its assets in 17.6M Savara shares, valued at 48.75M$.

Who is the top mutual fund holder of Savara shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Savara shares, with 2.96% of its total shares outstanding invested in 5.12M Savara shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools